Susan Lorincz Tablet is a compact reference tool designed to help clinicians quickly verify dosing, indications, and safety information for common medications. It bridges the gap between lengthy references and rapid point-of-care decisions, offering an organized format that supports accurate prescribing.
Digital and printable formats make this resource convenient for both clinic and ward use, emphasizing clarity, quick lookup, and practical applicability across routine cases. The following sections outline key specifications, clinical applications, safety considerations, and real-world usage insights.
| Feature | Specification | Clinical Relevance | Source |
|---|---|---|---|
| Target audience | Physicians, nurse practitioners, pharmacists | Supports prescribing decisions at point of care | Primary author guidelines |
| Content scope | Common inpatient and outpatient medications | Covers dosing, monitoring parameters, contraindications | Institutional formulary references |
| Update cycle | Quarterly revision schedule | Aligns with latest safety alerts and label changes | Internal editorial board |
| Available formats | Digital PDF, web portal, printable card | Flexible access from desktop or mobile devices | Publisher distribution channels |
Practical Clinical Use of Susan Lorincz Tablet
Quick Dosing Reference
Clinicians use the tablet to confirm weight-based and standard dosing ranges, reducing mental calculation errors. The layout groups medications by specialty area, allowing rapid navigation during busy shifts.
Monitoring Parameter Guidance
Each entry highlights key labs and timelines for monitoring, helping teams identify when additional follow-up is needed. This structured approach supports consistent care across shifts and service lines.
Safety Considerations and Contraindications
High-Risk Drug Alerts
The resource flags drugs with narrow therapeutic indices, potential for dangerous interactions, and specific contraindications. Prominent warnings encourage double-checking allergies, renal or hepatic impairment, and concurrent therapies.
Pediatric and Geriatric Guidance
Adjustments for age-related pharmacokinetic changes are summarized, with emphasis on starting at lower doses and titrating carefully. This focus helps minimize adverse drug events in vulnerable populations.
Integration with Electronic Health Records
Embedding Decision Support
Healthcare systems can incorporate selected content into EHR clinical decision support rules. Alerts derived from the tablet can prompt dose checks, allergy screening, and guideline-concordant ordering practices.
Workflow Optimization
By aligning the tablet content with existing order sets and protocols, teams reduce redundant lookups. Standardized links between the reference and EHR encourage consistent adherence to best practices.
Implementation and Best Practices
- Review institutional policies to align with tablet content before deployment
- Provide staff training on navigation, updates, and integration points
- Leverage digital formats for instant access and search functionality
- Establish a feedback channel for suggested updates and error reporting
- Schedule routine audits to ensure adherence to referenced guidelines
FAQ
Reader questions
Who is the Susan Lorincz Tablet designed for in a hospital setting?
It is tailored for physicians, nurse practitioners, pharmacists, and other clinicians who need rapid access to accurate dosing and safety information during patient care.
How frequently is the content updated to reflect new drug safety information?
The resource follows a quarterly revision cycle to incorporate the latest labeling changes, safety communications, and evidence-based guideline updates.
Can this tablet reference be used in outpatient clinics and community pharmacies?
Yes, it is designed for both inpatient and outpatient use, providing concise information that supports accurate prescribing and dispensing in varied practice settings.
What steps should a team take to integrate the tablet with existing clinical workflows?
Teams should map existing order sets and EHR alerts to the tablet content, then pilot the integration in one service line before expanding and monitoring for adherence and safety outcomes.